Company: BDRX
Filing Date: 2025-04-29
Form Type: POS AM
Source: 0001214659-25-006581
Chunk: 24

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-04-29
Form: POS AM
Chunk 24
---
holder under the Purchase Agreement will be determined
by us in our sole discretion, subject to the satisfaction of certain conditions in the Purchase Agreement, and will depend upon market
conditions and other factors. We may ultimately decide to sell to the Selling Shareholder all, some or none of the Depositary Shares that
may be available for us to sell to the Selling Shareholder pursuant to the Purchase Agreement. If we elect to sell Depositary Shares to
the Selling Shareholder pursuant to the Purchase Agreement, after the Selling Shareholder has acquired such shares, the Selling Shareholder
may resell all, some or none of such Depositary Shares at any time or from time to time in its discretion and at different prices. As
a result, investors who purchase Depositary Shares from the Selling Shareholder in this offering at different times will likely pay different
prices for those shares of Depositary Shares, and so may experience different levels of dilution and in some cases substantial dilution
and different outcomes in their investment results. See “Risk Factors-Risks Related to the Committed Equity Financings-Investors who buy Depositary Shares from the Selling Shareholder at different times will likely pay different prices.”

Investors may experience a
decline in the value of the Depositary Shares they purchase from the Selling Shareholder in this offering as a result of future sales
made by us to the Selling Shareholder at prices lower than the prices such investors paid for their shares in this offering. In addition,
if we sell a substantial number of Depositary Shares to the Selling Shareholder under the Purchase Agreement, or if investors expect that
we will do so, the actual sales of Depositary Shares or the mere existence of our arrangement with the Selling Shareholder may make it
more difficult for us to sell equity or equity-related securities in the future at a time and at a price that we might otherwise wish
to effect such sales.

Because the purchase price
per share to be paid by the Selling Shareholder for the Depositary Shares that we may elect to sell to the Selling Shareholder under the
Purchase Agreement, if any, will fluctuate based on the market prices of our Depositary Shares at the time we make such election, as of
the date of this prospectus, it is not possible for us to predict the number of Depositary Shares that we will sell to the Selling Shareholder
under the Purchase Agreement, the actual purchase price per share to be paid by the Selling Shareholder for those Depositary Shares, or
the actual